BCHE and Alzheimer disease: It is envisioned that the treatment of AD would benefit from the use of multipotent drugs that target at least two or more key pathophysiological processes linked to AD, such as cholinesterases (AChE and/or BChE) and β-secretase activities as well oxidative stress [9,10].